A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Lupus Nephritis
Interventions
DRUG

Mizoribine (MZR)

DRUG

Cyclophosphamide (CTX)

Trial Locations (26)

Unknown

Beijing Friendship Hospital, Capital Medical University, Beijing

China-Japan Friendship Hospital, Beijing

Chinese PLA General Hospital, Beijing

Peking University People's Hospital, Beijing

The Third Affiliated Hospital of the Third Military Medical University (Daping Hospital), Chongqing

The first Affiliated Hospital of Fujian Medical University, Fuzhou

Affiliated Hospital of Guilin Medical University, Guilin

The First Affiliated Hospital of Guangxi Medical University, Nanning

The Third Hospital of Hebei Medical University, Shijiazhuang

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Renmin Hospital of Wuhan University, Wuhan

Zhongnan Hospital of Wuhan University, Wuhan

Wuxi People's Hospital, Wuxi

The Second Hospital of Jilin University, Changchun

The First Affiliated Hospital of Dalian Medical University, Dalian

The General Hospital of Shenyang Military Region, Shenyang

Shandong Provincial Hospital, Jinan

The General Hospital of Jinan Military Region, Jinan

The Affilited Hospital of Qingdao University, Qingdao

Renji Hospital Shanghai Jiaotong University School of Medical, Shanghai

Zhongshan Hospital Fudan University, Shanghai

The Second Hospital of Shanxi Medical University, Taiyuan

The First Affiliated Hospital of the Fourth Military Medical University (Xijing Hospital), Xian

West China Hospital of Sichuan University, Chengdu

Kuming General Hospital of Chengdu Military Region, Kunming

The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Asahi Kasei Pharma Corporation

INDUSTRY

NCT02256150 - A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis | Biotech Hunter | Biotech Hunter